MiNK Therapeutics, Inc. Business Finance Contracts & Agreements
10 Contracts & Agreements
- Note Agreements (5 contracts)
- Stock Agreements (4)
- Underwriting Agreements (1)
- Stock Purchase Agreement, by and between MiNK Therapeutics, Inc. and the investor named therein, dated May 13, 2024 (Filed With SEC on August 13, 2024)
- Convertible Promissory Note Purchase Agreement by and between the Registrant and Agenus Inc., dated February 12, 2024 (Filed With SEC on March 21, 2024)
- Form of Convertible Promissory Note by and between the Registrant and Agenus Inc., dated February 12, 2024 (Filed With SEC on March 21, 2024)
- MiNK Therapeutics, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on October 12, 2021)
- Amendment to Convertible Promissory Note, by and between MINK Therapeutics, Inc. and Agenus Inc., dated September 29, 2021 (Filed With SEC on October 12, 2021)
- Specimen stock certificate evidencing shares of common stock (Filed With SEC on October 12, 2021)
- Form of Underwriting Agreement (Filed With SEC on October 12, 2021)
- Restricted Stock Award Agreement between AgenTus Therapeutics, Inc. and Patrick Jordan, dated November 5, 2020 (Filed With SEC on September 14, 2021)
- Convertible Promissory Note Purchase Agreement, by and between AgenTus Therapeutics, Inc. and Agenus Inc., dated February 11, 2021 (Filed With SEC on September 14, 2021)
- Convertible Promissory Note, by and between AgenTus Therapeutics, Inc. and Agenus Inc., dated February 11, 2021 (Filed With SEC on September 14, 2021)
